Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
- Status
- COMPLETED
- Phase
- PHASE2
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE3
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- Status
- TERMINATED
- Phase
- PHASE3
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL
- Status
- COMPLETED
- Phase
- PHASE2
Autologous Transplantation for Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2